- Boehringer agrees new partnership to advance first-in-class precision cancer therapies April 23, 2025
- Antibody treatment demonstrates potential in lupus kidney disease April 22, 2025
- FDA approves novel therapy for chronic skin condition April 21, 2025
- Eli Lilly releases topline data for new oral GLP-1 April 18, 2025
- New drug delivery method for cell therapies reported April 17, 2025
- European Commission Alzheimer’s drug approval marks advancement for EU patients April 16, 2025
- Celltrion Adalimumab Biosimilar Granted Interchangeability Designation April 18, 2025
- FDA to Phase Out Animal Testing for Monoclonal Antibodies and Other Drugs April 15, 2025
- FDA Approves Biocon Biologics’ Bevacizumab Biosimilar April 11, 2025
- Teva and Samsung Bioepis Announce U.S. Launch of EPYSQLI® (eculizumab-aagh), a SOLIRIS® Biosimilar April 9, 2025
- GSK and Pfizer Stipulate to Dismissal of RSV Vaccines Lawsuit April 7, 2025
- Smaller Pharmacies, Bigger Impact: Inside Manufacturers’ Specialty Networks in 2025 April 23, 2025
- Visit Drug Channels in Booth #1601 at #Asembia25 for a Special “Ask Adam Anything” (#AAA) Session April 21, 2025
- The AI Advantage: When and Where to Apply It in Your Patient Support Program April 17, 2025
- The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market April 16, 2025
- Master the Hidden Economics of Pharmaceuticals—In Under an Hour—with DCI's New eLearning Modules April 15, 2025
- The Hidden Costs of Data Silos: How Pharma Manufacturers Can Stop Revenue Leaks and Strengthen Security April 11, 2025
- Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: DCI’s 2025 Update and Competitive Outlook April 9, 2025